Literature DB >> 7041116

Growth of hybridoma cells in serum-free medium: ethanolamine is an essential component.

H Murakami, H Masui, G H Sato, N Sueoka, T P Chow, T Kano-Sueoka.   

Abstract

A serum-free medium supplemented with a few growth factors was devised to grow lymphocyte hybridomas. The medium was developed with the hybridoma line MPC11-BL, a fusion product between a mouse plasmacytoma cell line (MPC11TG70na3) and mouse (BALB/c) spleen cells. In the process of developing the medium, ethanolamine was found to be an essential growth factor for the hybridoma. Phosphoethanolamine at 10-fold higher concentration could substitute for ethanolamine. Long-term cultivation of the cells was achieved in the defined medium supplemented with insulin, transferrin, ethanolamine, and selenium. The defined medium supported the growth of various other mouse hybridoma cell lines, mostly at a rate comparable to that observed in a serum-containing medium. After one-step ammonium sulfate precipitation of the spent medium, more than 95% of the protein recovered was immunoglobulin as shown by NaDodSO4/polyacrylamide gel electrophoresis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7041116      PMCID: PMC345920          DOI: 10.1073/pnas.79.4.1158

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  Assembly and secretion of pentameric IgM in a fusion between a nonsecreting B cell lymphoma and an IgG-secreting plasmacytoma.

Authors:  W C Raschke; E L Mather; M E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

2.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

3.  A synthetic tripeptide which increases survival of normal liver cells, and stimulates growth in hepatoma cells.

Authors:  L Pickart; L Thayer; M M Thaler
Journal:  Biochem Biophys Res Commun       Date:  1973-09-18       Impact factor: 3.575

4.  Studies on a serum substitute for mammalian cells in culture. 2. Analyses of fractionated peptone dialysate and the use of glycine peptides.

Authors:  W G Taylor; V J Evans; R W Pumper
Journal:  In Vitro       Date:  1974 Jan-Feb

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Growth of a rat neuroblastoma cell line in serum-free supplemented medium.

Authors:  J E Bottenstein; G H Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

Review 7.  Methods for growth of cultured cells in serum-free medium.

Authors:  D Barnes; G Sato
Journal:  Anal Biochem       Date:  1980-03-01       Impact factor: 3.365

8.  The growth of cells in serum-free hormone-supplemented media.

Authors:  J Bottenstein; I Hayashi; S Hutchings; H Masui; J Mather; D B McClure; S Ohasa; A Rizzino; G Sato; G Serrero; R Wolfe; R Wu
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

9.  Phosphoethanolamine as a growth factor of a mammary carcinoma cell line of rat.

Authors:  T Kano-Sueoka; D M Cohen; Z Yamaizumi; S Nishimura; M Mori; H Fujiki
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

10.  Hormonal control of human colon carcinoma cell growth in serum-free medium.

Authors:  H Murakami; H Masui
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

View more
  86 in total

1.  Concanavalin A stimulation enhanced secondary VlambdaJlambda rearrangement in some human plasma B cells without up-regulation of recombination-activating gene expression and Vlambda germline transcription.

Authors:  H Haruta; H Tachibana; K Yamada
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

2.  Polyunsaturated fatty acids are not essential for survival and proliferation of a human B cell line.

Authors:  Y Miyazaki; M Noguchi; H Tachibana; K Yamada
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001 Jul-Aug       Impact factor: 2.416

3.  Growth and death behaviour of anchorage-independent animal cells immobilized within porous support matrices.

Authors:  H Yamaji; H Fukuda
Journal:  Appl Microbiol Biotechnol       Date:  1992-05       Impact factor: 4.813

Review 4.  Serum-free medium for fermentor cultures of hybridomas.

Authors:  O W Merten; J Litwin
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

5.  Long-term cultivation of anchorage-independent animal cells immobilized within reticulated biomass support particles in a circulating bed fermentor.

Authors:  H Yamaji; H Fukuda
Journal:  Appl Microbiol Biotechnol       Date:  1991-03       Impact factor: 4.813

6.  Increased antigen binding strengths of hybrid antibodies produced by human hybrid hybridomas.

Authors:  H Tachibana; S Shirahata; H Kawahara; H Murakami
Journal:  Cytotechnology       Date:  1991-09       Impact factor: 2.058

7.  Establishment and characterization of monoclonal antibodies against Chuzan virus K-47.

Authors:  N Eto; K Yamada; A Koga; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1991-05       Impact factor: 2.058

8.  Phosphatidylserine functions as the major precursor of phosphatidylethanolamine in cultured BHK-21 cells.

Authors:  D R Voelker
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

9.  Recombinant perchloric acid-soluble protein suppresses the immunoglobulin production of human-human hybridoma HB4C5 cells.

Authors:  Hiroaki Kanouchi; Aya Matsuo; Tatsuzo Oka; Hirofumi Tachibana; Koji Yamada
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Jul-Aug       Impact factor: 2.416

10.  Rational development of a serum-free medium and fed-batch process for a GS-CHO cell line expressing recombinant antibody.

Authors:  Huifeng Zhang; Haibin Wang; Mei Liu; Tao Zhang; Ji Zhang; Xiangjing Wang; Wensheng Xiang
Journal:  Cytotechnology       Date:  2012-08-21       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.